Abstract
The objective of this study was to determine if the nephrotoxic effects induced by cisplatin were correlated to mitochondrial DNA damage. Comparisons were made with the liver since hepatotoxicity is rarely observed. Cisplatin doses of 10, 20 and 40 mg/kg were administered intraperitoneally to C57BL/6J mice. Mitochrondrial DNA was isolated from both the hepatic and renal tissues and quantitated by hybridization with a specific mitochondrial probe. Cisplatin caused differential effects on mouse hepatic and renal mitochondrial DNA. The 10 and 20 mg/kg dose caused an elevation in mitochondrial DNA levels in the hepatic, but no increase in the renal tissue was observed. This is the first study demonstrating an organ specific effect of cisplatin at the DNA level.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Weiss RB, Poster DS: The renal toxicity of cancer chemotherapeutic agents. Cancer Treat Rev 9: 37–56, 1982
Zwelling LA, Anderson T, Kohn KW: DNA-protein and DNA interstrand crosslinking by cis and trans platinum (II) diamminedichloride in L1210 mouse leukemia cells and related to cytotoxicity. Cancer Res 39: 365–369, 1979
Plooy ACM, van Dijk M, Lehmann PH: Induction and repair of DNA crosslinks in Chinese Hamster Ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA cytotoxicity, mutagenicity and antitumor activity. Cancer Res 44: 2043–2051, 1984
Harder HC, Rosenberg B: Inhibitory effects of antitumor platinum compounds on DNA, RNA and protein synthesis in mammalian cells in vitro. Cancer 6: 207–216, 1970
Harder HC, Smith RG, Leroy E: Template primer inactivation by cis and trans dichlorodiammineplatinum for human DNA polymerase a,b and Rausher murine leukemia virus reverse transcriptase as a mechanism of cytotoxicity. Cancer Res 36: 3821–3829, 1976
Gray MW: Mitochondrial genome diversity and the evolution of mitochondrial DNA. Can J Biochem 60: 151–171, 1982
Brown WM, George M, Wilson AC: Rapid evolution of animal mitochondrial DNA (Abstr). Proc Nat Acad Sci USA 76: 1967–1971, 1979
Clayton DA: Transcription of the mammalian mitochondrial genome. Am Rev Biochem 53: 573–594, 1984
Salazar I, Tarrago-Litvak L, Gil L, Litvak S: The effect of benzo(a)pyrene on DNA synthesis and DNA polymerase activity of rat liver mitochondria. FEBS Lett 138: 43–49, 1982
Clayton DA, Doda IN, Fiedberg ED: The absence of a pyrimidine dimer repair mechanism in mammalian mitochondria. Proc Nat Acad Sci USA 71: 2777–2781, 1974
Allen JA, Coombs MM: Covalent binding of polycyclic aromatic compounds to mitochondria and nuclear DNA. Nature 287: 244–245, 1980
Backer JM, Weinstein IB: Mitochondrial DNA is a major cellular target for a dihydrodiol-epoxide derivative of benzo (a)pyrene. Science 209: 297–299, 1980
Backer JM, Weinstein IB: Interaction of benzo(a)pyrene and its dihydrodiol-epoxide derivative with nuclear and mitochondrial DNA in C3H10T1/2 cell cultures. Cancer Res 42: 2764–2769, 1982
Niranjan BG, Bhat NK, Avadhani NG: Preferential attack of mitochondrial DNA by aflatoxin B1 during hepatocarcinogenesis. Science 215: 73–75, 1982
Singh G, Hauswirth WW, Warren ER, Neims AH: A method for assessing damage to mitochondrial DNA caused by radiation and epichlorohydrine. Melee Pharmac 27: 167–170,1985
Lim LO, Neims AH: Mitochondrial DNA damage by bleomycin. Biochem Pharmacol 36: 2769–2774, 1987
Dobyan DC, Levi J, Jacobs C, Kosek J, Weiner MW: Mechanisms of cisplatinum nephrotoxicity. J Pharmacol Exp Ther 213: 551–556, 1980
Tisher CA: Anatomy of the Kidney. In: Brenner and Rector (eds) The Kidney. W.B. Saunders Co., Philadelphia, 1981, vol. 1, pp. 28–35
Singh G: Cisplatin-induced nephrotoxicity. Can Fed Biol Soc. 29: 136, 1986
Beltrame M, Sindellari L, Arslan P: Effects of newly synthesized platinum (II) complexes on mitochondrial functions. Chem Biol Interact 50: 247–254, 1984
Binet A, Volfin P: Effect of an antitumor platinum complex, Pt (II) diaminotoluene, on mitochondrial membrane properties. Biochim Biophys Acta 461: 182–187, 1977
Pederson PL, Greenwall JW, Reynafarje B, Hullinhen J, Decker G, Soper JW, Bustamante G: Preparation and characterization of mitochondria and submitochondrial particles of rat liver and liver derived tissues. Meth Cell Biol 20: 411–481, 1978
Lowry OH, Rosenbrough NJ, Farr NJ, Randall RJ: Protein measurement with the folin phenol reagent. J Biol Chem 193: 265–275, 1951
Rosenberg B: Antitumor activity of cis-dichlorodiammineplatinum (II) and some relevant chemistry. Cancer Treat Rep 63: 1433–1438, 1979
Madias NE, Harrington JT: Platinum nephrotoxicity. Am J Med 65: 307–314, 1978
Choie DD, Del Campo AA, Guarino AM: Subcellular localization of cisdichlorodiammineplatinum (II) in rat kidney and liver. Toxicol Appl Pharm 55: 245–252, 1980
Singh G, Koropatnick J: Differential toxicity of cis and trans isomers of dichlorodiammineplatinum. J Biochem Toxicol 3: 223–233, 1988
Litterst CL, Bertolero F, Uozomi J: The role of glutathione and metallothionein in the toxicity and subcellular binding of cisplatin. In: DCH McBrien and TF Slater (eds) Biochemical Mechanisms of Platinum Antitumor Drugs. IRL Press Limited, Oxford, England, 1986, pp 227–254
Dobyan PC, Levi J, Jacobs C, Kosek J, Weiner MW: Mechanisms of cisplatinum nephrotoxicity. II. Morphological observations. J Pharm Exp Therap 213(3): 551–556, 19??
Zaccarato F, Nicholls D: The role of phosphate in the regulation of the independent calcium-efflux pathway of liver mitochondria. Eur J Biochem 127: 333–338, 1982
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Maniccia-Bozzo, E., Bueno Espiritu, M. & Singh, G. Differential effects of cisplatin on mouse hepatic and renal mitochrondrial DNA. Mol Cell Biochem 94, 83–88 (1990). https://doi.org/10.1007/BF00223565
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00223565